山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2015年
21期
23-25
,共3页
李玲华%袁少静%刘杰%王敏%骆岚%隋晨辉%朱济英
李玲華%袁少靜%劉傑%王敏%駱嵐%隋晨輝%硃濟英
리령화%원소정%류걸%왕민%락람%수신휘%주제영
糖尿病肾病%复方红景天%尿微量白蛋白%晚期氧化蛋白产物%大鼠
糖尿病腎病%複方紅景天%尿微量白蛋白%晚期氧化蛋白產物%大鼠
당뇨병신병%복방홍경천%뇨미량백단백%만기양화단백산물%대서
diabetic nephropathy%compound rhodiola sachalinensis(Fufang Hongjingtian)%urinary microalbumin%advanced oxidation protein products%rats
目的:观察复方红景天喂食2型糖尿病肾病大鼠尿微量白蛋白( mALB )和血晚期氧化蛋白产物( AOPPs)的变化,并探究其保护肾脏的作用机制。方法将SPF级8周龄雄性Wistar大鼠50只随机分为正常对照组5只和模型组45只。将成功制作的43只糖尿病肾病模型再随机分为模型对照组10只、小剂量红景天组11只、中剂量红景天组11只、大剂量红景天组11只。小、中、大剂量红景天组分别给予复方红景天3、6、12 g/(kg· d ),模型对照组给予等体积生理盐水,连续灌胃4周。治疗前后尾静脉取血检测FBG、FINS、HOMR-IR、TG、TC、AOPPs及12 h尿mALB水平,并观察大鼠体质量( BW)的变化。结果治疗前,糖尿病肾病模型大鼠BW低于正常对照组,FPG、FINS、HOMR-IR、TG、TC、mALB、AOPPs水平均高于正常对照组( P<0.05或<0.01)。治疗4周后,小、中、大剂量红景天组BW均高于模型对照组,FPG、AOPPs、mALB水平低于模型对照组( P均<0.01),小、中、大剂量红景天组BW、AOPPs、mALB水平比较差异无统计学意义(P均>0.05)。结论复方红景天可能通过降低T2DN大鼠尿mALB、血AOPPs水平,从而发挥肾脏保护作用。
目的:觀察複方紅景天餵食2型糖尿病腎病大鼠尿微量白蛋白( mALB )和血晚期氧化蛋白產物( AOPPs)的變化,併探究其保護腎髒的作用機製。方法將SPF級8週齡雄性Wistar大鼠50隻隨機分為正常對照組5隻和模型組45隻。將成功製作的43隻糖尿病腎病模型再隨機分為模型對照組10隻、小劑量紅景天組11隻、中劑量紅景天組11隻、大劑量紅景天組11隻。小、中、大劑量紅景天組分彆給予複方紅景天3、6、12 g/(kg· d ),模型對照組給予等體積生理鹽水,連續灌胃4週。治療前後尾靜脈取血檢測FBG、FINS、HOMR-IR、TG、TC、AOPPs及12 h尿mALB水平,併觀察大鼠體質量( BW)的變化。結果治療前,糖尿病腎病模型大鼠BW低于正常對照組,FPG、FINS、HOMR-IR、TG、TC、mALB、AOPPs水平均高于正常對照組( P<0.05或<0.01)。治療4週後,小、中、大劑量紅景天組BW均高于模型對照組,FPG、AOPPs、mALB水平低于模型對照組( P均<0.01),小、中、大劑量紅景天組BW、AOPPs、mALB水平比較差異無統計學意義(P均>0.05)。結論複方紅景天可能通過降低T2DN大鼠尿mALB、血AOPPs水平,從而髮揮腎髒保護作用。
목적:관찰복방홍경천위식2형당뇨병신병대서뇨미량백단백( mALB )화혈만기양화단백산물( AOPPs)적변화,병탐구기보호신장적작용궤제。방법장SPF급8주령웅성Wistar대서50지수궤분위정상대조조5지화모형조45지。장성공제작적43지당뇨병신병모형재수궤분위모형대조조10지、소제량홍경천조11지、중제량홍경천조11지、대제량홍경천조11지。소、중、대제량홍경천조분별급여복방홍경천3、6、12 g/(kg· d ),모형대조조급여등체적생리염수,련속관위4주。치료전후미정맥취혈검측FBG、FINS、HOMR-IR、TG、TC、AOPPs급12 h뇨mALB수평,병관찰대서체질량( BW)적변화。결과치료전,당뇨병신병모형대서BW저우정상대조조,FPG、FINS、HOMR-IR、TG、TC、mALB、AOPPs수평균고우정상대조조( P<0.05혹<0.01)。치료4주후,소、중、대제량홍경천조BW균고우모형대조조,FPG、AOPPs、mALB수평저우모형대조조( P균<0.01),소、중、대제량홍경천조BW、AOPPs、mALB수평비교차이무통계학의의(P균>0.05)。결론복방홍경천가능통과강저T2DN대서뇨mALB、혈AOPPs수평,종이발휘신장보호작용。
Objective To observe the changes of microalbuminuria ( mALB) and advanced oxidation protein products ( AOPPs ) of rats with type 2 diabetic nephropathy ( T2DN) by feeding compound rhodiola sachalinensis ( Fufang Hongjin-tian) and to investigate its mechanism of protecting the kidney.Methods Fifty male 8-week-old Wistar rats were random-ly divided into the normal control group (A group, n=5) and model group (n=45).During the 45 rats, 43 rat models with DN were successfully made.Then, they were randomly divided into the model control group (group B, n=10), low dose compound rhodiola sachalinensis group ( group C) , medium-dose compound rhodiola sachalinensis group ( group D, n=11), and high-dose compound rhodiola sachalinensis group (group E, n=11).Rats in the groups C, D and E were treated by 3, 6 and 12 g/( kg· d) compound rhodiola sachalinensis and rats in the group B was treated by intragastric ad-ministration of the same amount of normal saline for 4 weeks.The FBG, FINS, HOMR-IR, TG, TC, AOPPs and 12-hour mALB level in the caudal vein of rats were detected before and after treatment and the body weight ( BW) was also ob-served.Results Before treatment, the BW of group B was significantly lower than that of group A, but FPG, FINS, HOMR-IR, TG, TC, mALB and AOPPs level was higher than that of group A (P<0.05 or P<0.01).After treatment of 4 weeks, the BW of groups C, D and E was higher than that of group B, but FPG, AOPPs and mALB was lower than that of the group B (all P<0.01).No statistical difference was found in FPG, AOPPs and mALB among groups C, D and E (all P>0.05).Conclusion Compound rhodiola sachalinensis (Fufang Hongjingtian) has the protective effect on kidney of T2DN rats by reducing the levels of mALB and AOPPs.